ClinConnect ClinConnect Logo
Search / Trial NCT06883357

The Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke.

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Mar 12, 2025

Trial Information

Current as of June 05, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a home-based rehabilitation program called the Graded Repetitive Arm Supplementary Program (GRASP), which is designed to help stroke patients improve the movement and function of their affected arm. The program encourages patients to practice specific arm movements at home, which research has shown can help with recovery after a stroke. The trial aims to understand how effective this program is when done in a group setting, particularly for stroke survivors in Taiwan.

To participate in this trial, individuals must be over 20 years old and have experienced a first stroke that has resulted in some weakness or paralysis on one side of their body. Participants should still be able to move their affected arm to some degree and follow simple instructions. If you are interested in joining, you’ll be part of a supportive group that will work together on improving your arm movements. It’s important to note that people with other serious health issues or certain recent treatments may not be eligible. This trial is currently recruiting participants, and it's a great opportunity for stroke survivors to take an active role in their recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age is above 20 years old.
  • 2. Onset of first stroke complicated with hemiplegia or hemiparesis.
  • 3. The affected upper limb remains partially voluntary movements including lifting to chest level and holding for five seconds; slight flexion and extension of wrist and hand.
  • 4. Understanding and complying with two-steps commands.
  • 5. Understanding the content of trial and willing to sign informed consent.
  • Exclusion Criteria:
  • 1. Complicating with other neurological disease.
  • 2. Having Orthopedic diseases affecting the movements of upper limbs.
  • 3. Having symptoms of pain to affect the movements of upper limbs.
  • 4. Unstable vital sign or medical condition.
  • 5. Participating another rehabilitative or drug research meanwhile.
  • 6. Receiving botulinum toxin injection within three months.

About National Taiwan University Hospital

National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.

Locations

Hsin Chu City, , Taiwan

Patients applied

0 patients applied

Trial Officials

Chia-Yi Lin

Study Director

Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital Hsin-Chu Branch

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported